Breast Surgery · Breast Cancer

Surgical Options and Axillary Staging

At a Glance

For upper-outer quadrant breast cancer, surgery may be a lumpectomy or mastectomy, and nearby armpit lymph nodes are often checked with a sentinel node biopsy. Some patients with limited node involvement can avoid full node removal, which lowers lymphedema risk.

When you face a diagnosis of breast cancer in the upper outer quadrant (UOQ), your surgical plan is often the first major step in your treatment journey. Because this area is close to the armpit, your breast surgery and your lymph node surgery are closely linked. Modern breast surgery is guided by two main goals: removing the cancer safely and minimizing the long-term impact on your quality of life ^[1]^[2].

Choosing Your Breast Surgery

There are two primary ways to surgically remove the cancer from your breast. For appropriately selected early-stage patients, the overall survival rates for both options are remarkably similar ^[1]^[3]. However, the choice is not simply a lifestyle preference; your doctor will consider the tumor-to-breast size ratio, whether you have multifocal disease, your genetic risk, and your medical fitness.

Lumpectomy (Breast-Conserving Surgery): The surgeon removes the tumor and a small “buffer” of healthy tissue around it. This allows you to keep the majority of your natural breast. To match the effectiveness of a mastectomy, it is almost always followed by radiation therapy (though radiation is occasionally omitted in carefully selected older, low-risk patients) ^[4]^[5].
Mastectomy: The surgeon removes the entire breast. While some patients feel a mastectomy is “safer,” it is a larger surgery with a longer recovery. Furthermore, having a mastectomy does not automatically eliminate the need for radiation; if you have large tumors or positive lymph nodes, post-mastectomy radiation may still be required ^[1]^[6].

Understanding Surgical Margins

Regardless of which surgery you have, pathologists check the edges of the removed tissue to ensure the cancer has been completely removed ^[7].

For invasive cancer treated with a lumpectomy and whole-breast radiation, the standard goal is “no ink on tumor”—meaning no cancer cells are touching the ink the pathologist painted on the outer edge of the tissue ^[7]^[8].
However, required margins can differ depending on your pathology (such as DCIS) or if you are having a mastectomy. If your margins are positive, a second surgery (a re-excision) may be necessary ^[9]^[10].

Axillary Staging: Checking the Lymph Nodes

Because the UOQ is the “gateway” to the lymph nodes in your armpit (axilla), staging these nodes is a vital part of your surgery.

The standard approach for clinically node-negative patients is a Sentinel Lymph Node Biopsy (SLNB). Your surgeon uses a tracer to identify the “sentinel” nodes—the very first nodes the cancer would reach ^[11].

If the sentinel nodes are clear, no further nodes need to be removed ^[12].
If the sentinel nodes contain cancer, your team must decide whether to remove more nodes or treat the area with radiation ^[13].

De-escalation: When Can We Do Less?

In the past, finding cancer in any lymph node meant an automatic Axillary Lymph Node Dissection (ALND)—removing most of the lymph nodes in the armpit (usually 10 to 20 nodes) ^[12].

Today, surgeons practice “de-escalation” based on landmark trials like Z0011 and AMAROS. These studies proved that some patients can safely skip ALND and use radiation and systemic therapy instead ^[11]^[13]. However, these rules do not apply to everyone.

Eligibility for De-escalation: Skipping ALND typically applies to clinically node-negative patients with smaller (T1-T2) tumors who have only 1 or 2 positive sentinel nodes, are having a lumpectomy with whole-breast radiation, and will receive systemic therapy ^[11]^[14].
ALND may still be required if you had neoadjuvant chemotherapy, chose a mastectomy, have bulky nodal disease, or have more extensive node involvement.

Managing the Risk of Lymphedema

The primary reason doctors try to avoid unnecessary ALND is to prevent lymphedema—a chronic condition where lymph fluid cannot drain properly, causing persistent arm swelling ^[2].

Risk with SLNB: The risk of lymphedema after removing just a few sentinel nodes is low, roughly 5% to 8% ^[2]^[15].
Risk with ALND: The risk jumps significantly with a full dissection, with estimates reaching 25% to 33% ^[2]^[16]. Radiation to the armpit can also increase this risk.

Your surgical team will work to preserve nodes while ensuring the cancer is safely addressed. For UOQ tumors, surgeons must also be particularly careful to protect the nerves that provide sensation to your inner arm and chest wall ^[17]^[18].

Common questions in this guide

How do I choose between a lumpectomy and a mastectomy for upper-outer quadrant breast cancer?

For appropriately selected early-stage patients, lumpectomy followed by radiation and mastectomy have similar overall survival. The decision also considers tumor size relative to the breast, multiple areas of disease, genetic risk, whether radiation is part of the treatment plan, and overall health.

What does “no ink on tumor” mean after breast cancer surgery?

A pathologist examines the edges of the tissue removed during surgery. For invasive cancer treated with lumpectomy and whole-breast radiation, “no ink on tumor” means no cancer cells touch the marked outer edge. A positive margin may require another surgery to remove more tissue, and the goal can differ for ductal carcinoma in situ or mastectomy.

What is a sentinel lymph node biopsy, and what happens if it finds cancer?

A sentinel lymph node biopsy uses a tracer to find and remove the first lymph nodes cancer would most likely reach in the armpit. If those nodes are clear, more nodes usually do not need to be removed; if cancer is found, the team may consider additional surgery or radiation based on the tumor and treatment plan.

Can I avoid a full axillary lymph node dissection if my sentinel nodes are positive?

Some people whose nodes appear negative before surgery, who have a smaller T1-T2 tumor, one or two positive sentinel nodes, a lumpectomy with whole-breast radiation, and planned systemic treatment may avoid a full axillary lymph node dissection. A mastectomy, bulky nodes, more extensive node involvement, or chemotherapy before surgery may mean that dissection is still recommended.

What is the risk of lymphedema after breast cancer lymph node surgery?

Lymphedema is long-term swelling caused by impaired lymph drainage. The risk is about 5% to 8% after sentinel node biopsy and may reach 25% to 33% after full axillary dissection; radiation to the armpit can increase the risk.

Will a mastectomy eliminate the need for radiation?

No. Mastectomy removes the breast, but radiation may still be recommended when the tumor is large or lymph nodes contain cancer. The final pathology and other treatment factors help determine whether radiation is needed.

Curated prompts to bring to your next appointment.

1.Am I a candidate for breast-conserving surgery (lumpectomy), and what would my breast look like afterward?
2.What are the specific margin goals for my type of surgery and pathology?
3.If my sentinel lymph node biopsy shows cancer cells, do I meet the criteria for skipping a full node dissection (ALND) in favor of radiation?
4.What steps will the surgical team take during the operation to protect the nerves that control sensation in my arm and chest?
5.Does your facility offer lymphedema screening or physical therapy before and after surgery to monitor for arm swelling?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Key takeaways

For appropriately selected early-stage patients, lumpectomy followed by radiation and mastectomy have similar overall survival.
Lumpectomy removes the tumor with surrounding tissue, while mastectomy removes the entire breast; radiation may be needed after either operation depending on pathology and lymph nodes.
Sentinel lymph node biopsy checks the first armpit nodes cancer would reach, and clear nodes usually do not require further removal.
Some clinically node-negative patients with smaller T1-T2 tumors and one or two positive sentinel nodes can avoid full axillary dissection when they have lumpectomy, whole-breast radiation, and systemic therapy.
Lymphedema risk is about 5% to 8% after sentinel node biopsy versus 25% to 33% after axillary dissection, and armpit radiation can increase risk.

References (18)

1
Adjuvant Radiotherapy in Early-Stage Breast Cancer: Evidence-Based Options.
Shah C, Tendulkar R, Smile T, et al.
Annals of surgical oncology 2016; (23(12)):3880-3890 doi:10.1245/s10434-016-5503-x.
PMID: 27557828
2
Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial.
Naoum GE, Roberts S, Brunelle CL, et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020; (38(29)):3430-3438 doi:10.1200/JCO.20.00459.
PMID: 32730184
3
Oncoplastic breast surgery in the setting of breast-conserving therapy: A systematic review.
Yoon JJ, Green WR, Kim S, et al.
Advances in radiation oncology 2016; (1(4)):205-215 doi:10.1016/j.adro.2016.09.002.
PMID: 28740889
4
Postoperative Radiotherapy After Breast-Conserving Surgery for Early-Stage Breast Cancer: A Review.
Speers C, Pierce LJ
JAMA oncology 2016; (2(8)):1075-82 doi:10.1001/jamaoncol.2015.5805.
PMID: 27243924
5
Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.
Kunkler IH, Williams LJ, Jack WJ, et al.
The Lancet. Oncology 2015; (16(3)):266-73.
PMID: 25637340
6
The Landmark Series: Adjuvant Radiation Therapy for Breast Cancer.
Valente SA, Shah C
Annals of surgical oncology 2020; (27(7)):2203-2211 doi:10.1245/s10434-020-08450-5.
PMID: 32314162
7
Margins in breast cancer: How much is enough?
Pilewskie M, Morrow M
Cancer 2018; (124(7)):1335-1341 doi:10.1002/cncr.31221.
PMID: 29338088
8
The Diminishing Impact of Margin Definitions and Width on Local Recurrence Rates following Breast-Conserving Therapy for Early-Stage Invasive Cancer: A Meta-Analysis.
Shah C, Hobbs BP, Vicini F, et al.
Annals of surgical oncology 2020; (27(12)):4628-4636 doi:10.1245/s10434-020-08878-9.
PMID: 32712894
9
Assessment of Practice Patterns Following Publication of the SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Therapy in Stage I and II Invasive Breast Cancer.
DeSnyder SM, Hunt KK, Smith BD, et al.
Annals of surgical oncology 2015; (22(10)):3250-6 doi:10.1245/s10434-015-4666-1.
PMID: 26202554
10
Close and Positive Lumpectomy Margins are Associated with Similar Rates of Residual Disease with Additional Surgery.
Fitzgerald S, Romanoff A, Cohen A, et al.
Annals of surgical oncology 2016; (23(13)):4270-4276 doi:10.1245/s10434-016-5490-y.
PMID: 27581606
11
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Giuliano AE, Ballman KV, McCall L, et al.
JAMA 2017; (318(10)):918-926 doi:10.1001/jama.2017.11470.
PMID: 28898379
12
[Strategies in case of metastatic sentinel lymph node in breast cancer].
Costaz H, Rouffiac M, Boulle D, et al.
Bulletin du cancer 2020; (107(6)):672-685 doi:10.1016/j.bulcan.2019.09.005.
PMID: 31699399
13
Can axillary radiotherapy replace axillary dissection for patients with positive sentinel nodes? A systematic review and meta-analysis.
Zhao M, Liu WG, Zhang L, et al.
Chronic diseases and translational medicine 2017; (3(1)):41-50 doi:10.1016/j.cdtm.2017.01.005.
PMID: 29063055
14
AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025.
Reimer T, Kuehn T, Mueller V, et al.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2025; (51(11)):110445 doi:10.1016/j.ejso.2025.110445.
PMID: 40983010
15
Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.
Liu S, Wang N, Gao P, et al.
World journal of surgical oncology 2020; (18(1)):118 doi:10.1186/s12957-020-01886-9.
PMID: 32482174
16
Axillary dissection vs. non-axillary dissection in breast cancer patients with sentinel lymph node metastasis: An updated systematic review and meta-analysis of randomized clinical trials.
Castelo Branco PES, Carneiro IMC, Franco AHS, et al.
Surgical oncology 2026; (66()):102442 doi:10.1016/j.suronc.2026.102442.
PMID: 42066648
17
Evaluation of Axilla With Sentinel Lymph Node Biopsy (Using Methylene-Blue) and Reverse Axillary Mapping (Using Fluorescein) to Validate Optimum and Safe Axillary Dissection in Breast Cancer.
Puthangot A, Chintamani C, Tandon M
Cureus 2023; (15(9)):e45267 doi:10.7759/cureus.45267.
PMID: 37846283
18
Indocyanine Green Fluorescence-Guided Axillary Reverse Mapping for Axillary Lymph Node Dissection in Breast Cancer: The FARM Trial.
Nguyen CL, Poels D, Teoh B, et al.
Annals of surgical oncology 2025; (32(12)):8701-8709 doi:10.1245/s10434-025-17703-0.
PMID: 40549090

This page is for informational purposes only and does not constitute medical advice. Your breast surgeon and oncology team should tailor the choice of breast and lymph-node surgery, radiation, and lymphedema monitoring to your pathology and overall health.

Get notified when new evidence is published on female breast upper-outer quadrant cancer.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents